BIORESS · Bioactive resorbable scaffolds for drug delivery in bone tissue engineering
FP7 — People (Marie Curie Actions)
- Duration
- 2008-01-15 → 2011-01-14
- EU contribution
- €45,000
- Participants
- 1
- Scheme
- MC-ERG
Lines connect the coordinator with its partners.
Results in brief
Bioactive resorbable scaffolds for drug delivery in bone tissue engineering
Bone replacements are frequently required to substitute damaged tissue due to any trauma, disease or surgery. The current therapies for bone grafts: autografts (taken directly from the patient), allografts (taken from a cadaver donor) or xenograft (taken from animals), are limited in availability and can be associated with patient morbidity or with the risk of inducing transmissible diseases. The development of synthetic tissue-engineered bone scaffold substitutes is one of the most important topics in the bone tissue engineering field. A bone scaffold is a three-dimensional (3D) porous structure that can be used as a bone graft or bone filling material. It should have good mechanical properties to support the structural loads and high porosity to allow tissue in-growth and vascularisation, cell adhesion, migration and proliferation. Scaffolds made of phosphate glasses are an attractive solution. Phosphate glasses are resorbable and the degradation kinetics can be controlled by their composition. They are biocompatible, bioactive (has ability to develop a chemical bond with the newly formed bone tissue, by precipitation of hydroxylapatite (HA) layer similar with the one found in natural bone) and osteoconductive (has ability to support bone growth over its surface), making them useful as bone fillers and drug delivery systems. The aim of this project was the development, characterisation and in vitro experimentation of novel macroporous scaffolds with highly interconnected porosity and controlled biodegradability for drug delivery in bone tissue engineering. The main objectives of this project were: 1. synthesis and characterisation of bioactive and bioresorbable phosphate glasses; 2. synthesis and characterisation of bioactive and bioresorbable scaffolds; 3. in vitro biological characterisation of the scaffolds. Phosphate glasses belonging to the complex system P2O5-SiO2-Na2O-CaO-MgO-K2O were obtained by a traditional melting and quenching method. They were then characterised in terms of microstructure, solubility and bioactivity. The results show that the glass is bioactive (a HA layer is formed on the glass surface after immersion in a SBF) and bioresorbable. It lost almost 76 wt.% after 4 months of immersion in distilled water. The dissolution takes place by a congruent surface erosion mechanism. The glass was further used to produce macroporous 3D-scaffolds for bone regeneration. The scaffolds were fabricated by using the burning-out method. This method, involves the use of an organic phase as porogen, which is mixed with inorganic particles (the glass powder in this case). The mixture is pressed, obtaining a green body, and then it is heat treated to remove the organic phase (by burning) and to sinter the inorganic particles. The heat treatment process was optimised in order to provide a better control of the scaffold microstructure and to enhance the mechanical properties. The obtained scaffolds were characterised in terms of microstructure, solubility, bioactivity and mechanical strength. Biocompatibily was evaluated in vitro, using human marrow stromal cells. The results show that the obtained scaffolds have a porosity of 80-90 vol%, with a high degree of interconnection. The maximum compressive strength was 2 ± 0.5 MPa. After 4 months of soaking in SBF, the scaffolds lost almost 76 wt.% with a pH not exceeding the 7.45 value. Morphological and biochemical assays with human marrow-derived stromal cells seeded on scaffolds showed that the cells maintain their metabolic activity and ability to proliferate on the scaffolds. To conclude, during this project, a new bioactive and bioresorbable phosphate glass was produced and characterised. This glass was then utilised to produce bioactive and bioresorbable scaffold with highly porous structure and interconnected porosity for bone tissue engineering. It has shown a stimulatory effect in promoting osteogenesis.
Data: CORDIS, © European Union
Project objective
Bone tissue engineering is a new research area with clinical applications in the replacement of diseased or damaged bone tissues. The challenge of tissue engineering is to develop a suitable bone scaffold with sufficient porosity and mechanical strength to allow a good integration with the surrounding tissues. Bioactive resorbable scaffolds that combine the characteristics of materials for bone tissue engineering with the one of drug delivery systems, are an innovative approach in materials engineering field. By implantation of these materials in the desired body location, they will release the therapeutic agent, improving the efficiency of the clinical treatment. Due to their bioactivity, they can be used as bone substitute, increasing the bone integration (osteointegration). Due to their biodegradation, they can control the kinetics releasing of the active agent. The scaffold porosity controls the amount of the therapeutic agent that can be incorporated. Therefore, the aim of this project is the development, characterisation and in vitro experimentation of novel macroporous scaffolds with highly interconnected porosity and controlled biodegradability for drug delivery in bone tissue engineering. Optimisation of the scaffold structure is essential to achieve both adequate mechanical and biological response in clinical applications. The macro and microstructure of the porous scaffolds will be investigated. Cell culturing experiments will be carried out to assess the biological behaviour of these materials. The scaffold surface will be functionalized in order to bind specific macromolecules (proteins, antibiotics, growth factors etc.) for drug delivery. The dependence of the drug delivery profiles on the scaffold biodegradation will be studied in vitro. We expect that these innovative materials will be useful as delivery systems for cells and biological molecules in bone tissue engineering applications.
Original text from CORDIS.
Participants
- POLITECNICO DI TORINO · TorinoCoordinatorItaly
Links
Data: CORDIS, © European Union
